Fasturtec

Fasturtec

rasburicase

Manufacturer:

Sanofi

Distributor:

DCH Auriga - Healthcare
/
Four Star
Concise Prescribing Info
Contents
Rasburicase
Indications/Uses
Treatment & prophylaxis of acute hyperuricaemia, in order to prevent acute renal failure, in patients w/ haematological malignancy w/ a high tumour burden & at risk of a rapid tumour lysis or shrinkage at initiation of chemotherapy.
Dosage/Direction for Use
0.2 mg/kg/day as a once daily 30 min IV infusion for 7 days.
Contraindications
Hypersensitivity. G6PD deficiency & other cellular metabolic disorders known to cause haemolytic anaemia.
Special Precautions
Monitor closely for onset of allergic-type undesirable effects, esp allergic skin reaction or bronchospasm. History of atopic allergies. Pregnancy & lactation.
Adverse Reactions
ATC Classification
V03AF07 - rasburicase ; Belongs to the class of detoxifying agents used in antineoplastic treatment.
Presentation/Packing
Form
Fasturtec powd for inj 1.5 mg
Packing/Price
3 × 1's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in